Skip to main content
Article
How did the 2003 Prescription Drug Re-importation Bill Pass the House?
Economics and Politics (2006)
  • Omer Gokcekus, Seton Hall University
  • M. Adams
  • H. Grabowski
  • E. Tower
Abstract
We examine the major interest groups in the debate over allowing the re-importation of prescription drugs by utilizing a logit model and instrumental variables. Consistent with political support approach, the evidence suggests that Representatives are maximizing their electoral prospects: contributions from pharmaceutical manufacturers shrink the probability of voting for the bill; and Representatives are sensitive to their constituencies – employees of pharmaceutical manufacturing and senior citizens. Representatives' gender and ideology regarding free trade and subsidies are also determining factors. However, the decision was, by and large, a partisan one: party affiliation was the most important factor in passing the bill.
Publication Date
March, 2006
DOI
10.1111/j.1468-0343.2006.00161.x
Citation Information
Omer Gokcekus, M. Adams, H. Grabowski and E. Tower. "How did the 2003 Prescription Drug Re-importation Bill Pass the House?" Economics and Politics Vol. 18 Iss. 1 (2006) p. 27 - 45
Available at: http://works.bepress.com/omer_gokcekus/11/